Nacuity Pharmaceuticals

Series-B+
nacuity.com Biotech & Healthcare
Total Funding $16.5M
Latest Round $16.5M Series-B+
Last Announced Jun 16, 2022
Investors Undisclosed
Decision Makers 5 Verified

About Nacuity Pharmaceuticals

Advancing a promising treatment for retinitis pigmentosa

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website nacuity.com
Domain Registered Date Aug 10, 2016

Social & Network Presence

X / Twitter Profile @nacuitypharma (87 followers) Created on Aug 2022
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Milestone

    X account created (@nacuitypharma)

    87 followers

  2. Capital Raise

    Raised $16,500,000 · Series-B+

    startupintros.com

  3. Milestone

    Website domain registered

    nacuity.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Nacuity Pharmaceuticals.

Funding History

1 Round
Series-B+ · Jun 16, 2022

Founders & Leadership

1

Halden Conner

Co-Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts